共济失调毛细血管扩张症中肺活量下降,气道阻力测定和寿命
FVC deterioration, airway obstruction determination, and life span in Ataxia telangiectasia
Daphna Vilozniee, Moran Lavie, Ifat Sarouk, Bat-El Bar-Aluma, Adi Dagan, Moshe Ashkenazi, Miryam Ofek, Ori Efrati
The Pediatric Pulmonary Unit and the Ataxia Telangiectasia National Clinic, The Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Affiliated with the Sackler Faculty of Medicine, Tel-Aviv University, Israel
Rationale
Forced vital capacity (FVC) values decrease with progress of the disease in Ataxia telangiectasia (AT).
Objective
To study the effect of this process on airway obstruction determination and life span in AT.
Methods
Clinical data and yearly best spirometry maneuvers were collected retrospectively from 37 AT patients (196 spirometry tests) during 5.4 ± 1.8yrs (initial age 4–21 y). Twelve patients were walking (7 of them had recurrent respiratory system infections); 25 subjects were confined to wheelchair, of them 8 patients were towards end-stage lung disease. Spirometry indices included Forced Vital Capacity (FVC), mid-expiratory-flow (FEF25-75), and tidal volume (VT). We calculated FEF25-75/FVC and VT/FVC ratios.
Results
FVC declined from 67 ± 8 while walking to 19 ± 6 %predicted values. FEF25-75 values that were elevated (116 ± 23 %predicted) while walking, decreased to 69 ± 27 %predicted at end-stage where 7 patients responded to bronchodilators. VT/FVC ratio was 0.25 ± 0.06 while walking, increased to 0.35 once on wheelchairs, and further increased to 0.57 ± 0.19 at end-stage disease. FEF25–75/FVC ratio was 2.54 ± 0.70 above normal (∼1.0) increasing to 4.16 ± 0.75 at end stage. A sharp elevation was seen in FEF25–75/FVC ratio when FEV1 was still ∼45 %predicted and 2-years prior to death.
Conclusions
Having a low baseline-FVC (60% predicted) artificially raises FEF25-75 values, so FEF25-75 of “mild obstruction” values may indicate severe airway obstruction in AT subjects. VT/FVC and FEF25-75/FVC ratios may therefore assist in revealing higher than normal breathing effort. The results further suggest adding VT/FVC and FEF25-75/FVC ratios to pulmonary function assessments in patients with AT.
respiratory medicine
July 2015Volume 109, Issue 7, Pages 890–896
DOI: http://dx.doi.org/10.1016/j.rmed.2015.05.013 |
copyright©金宝搏网站登录技巧 版权所有,未经许可不得复制、转载或镜像
京ICP证120392号 京公网安备110105007198 京ICP备10215607号-1 (京)网药械信息备字(2022)第00160号